Standout Papers
Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Works of Stacie Bell being referenced
Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota
2019
Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Stacie Bell | 94 | 246 | 38 | 125 | 99 | 31 | 564 | |
| Matthew Keller | 33 | 128 | 75 | 176 | 137 | 45 | 637 | |
| Michael Buslau | 43 | 347 | 14 | 245 | 59 | 19 | 585 | |
| P. Saïag | 70 | 96 | 37 | 155 | 79 | 28 | 521 | |
| M. J. Boffa | 148 | 176 | 23 | 142 | 58 | 21 | 511 | |
| Thomas Wendland | 107 | 184 | 39 | 118 | 30 | 18 | 649 | |
| F Hamerlinck | 45 | 184 | 39 | 135 | 59 | 26 | 505 | |
| Edgardo Chouela | 164 | 180 | 35 | 186 | 21 | 24 | 553 | |
| Anna Cristina Garza‐Mayers | 72 | 83 | 50 | 86 | 67 | 24 | 484 | |
| Ieda Maria Longo‐Maugéri | 40 | 226 | 29 | 57 | 112 | 32 | 544 | |
| Ali Tahsin Güneş | 48 | 69 | 104 | 146 | 46 | 41 | 494 |
All Works
Loading papers...